✦ LIBER ✦

The use of estrogen in the treatment of Parkinson's disease

✍ Scribed by K.L. Tsang; H. Jiang; D.B. Ramsden; S.L. Ho

Book ID: 117751755
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 175 KB
Volume: 8
Category: Article
ISSN: 1353-8020
DOI: 10.1016/s1353-8020(01)00027-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Using Liquid Levodopa in the Treatment o

Using Liquid Levodopa in the Treatment of Parkinson’s Disease

✍ Dr Matthias C. Kurth 📂 Article 📅 1997 🏛 Springer International Publishing AG 🌐 English ⚖ 885 KB

Use of growth factors for the treatment

Use of growth factors for the treatment of Parkinson’s disease

✍ Yasuda, Toru; Mochizuki, Hideki 📂 Article 📅 2010 🏛 Expert Reviews 🌐 English ⚖ 421 KB

Reproductive factors, exogenous estrogen

Reproductive factors, exogenous estrogen use, and risk of Parkinson's disease

✍ Kelly Claire Simon; Honglei Chen; Xiang Gao; Michael A. Schwarzschild; Alberto A 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB

## Abstract To determine if reproductive factors or exogenous estrogen are associated with risk of Parkinson's disease (PD), we conducted a prospective study with 22 years of follow‐up among postmenopausal participants in the Nurses' Health Study. Relative risks (RRs) and 95% confidence intervals (

The use of Clozapine in Parkinson's dise

The use of Clozapine in Parkinson's disease

✍ GONSKI, P. N. 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB

The use of famotidine in the treatment o

The use of famotidine in the treatment of Parkinson's disease: a pilot study

✍ S. P. Molinari; R. Kaminski; A. Di Rocco; M. D. Yahr 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 303 KB

New approaches in the use of selegiline

New approaches in the use of selegiline for the treatment of Parkinson's disease

✍ A. J. Lees; J. Frankel; V. Eatough; G. M. Stern 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 479 KB